<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Pediatr Parent</journal-id><journal-id journal-id-type="publisher-id">pediatrics</journal-id><journal-id journal-id-type="index">30</journal-id><journal-title>JMIR Pediatrics and Parenting</journal-title><abbrev-journal-title>JMIR Pediatr Parent</abbrev-journal-title><issn pub-type="epub">2561-6722</issn></journal-meta><article-meta><article-id pub-id-type="publisher-id">46555</article-id><article-id pub-id-type="doi">10.2196/46555</article-id><title-group><article-title>Associations Between Patient-Reported Outcome Measures of Physical and Psychological Functioning and Willingness to Share Social Media Data for Research Among Adolescents With a Chronic Rheumatic Disease: Cross-Sectional Survey</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Weitzman</surname><given-names>Elissa R</given-names></name><degrees>MSc, ScD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Minegishi</surname><given-names>Machiko</given-names></name><degrees>MSW, MPH, MD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cox</surname><given-names>Rachele</given-names></name><degrees>MPH</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wisk</surname><given-names>Lauren E</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff4">4</xref></contrib></contrib-group><aff id="aff1"><institution>Division of Adolescent/Young Adult Medicine, Boston Children&#x2019;s Hospital</institution>, <addr-line>Boston</addr-line><addr-line>MA</addr-line>, <country>United States</country></aff><aff id="aff2"><institution>Department of Pediatrics, Harvard Medical School</institution>, <addr-line>Boston</addr-line><addr-line>MA</addr-line>, <country>United States</country></aff><aff id="aff3"><institution>Division of Addiction Medicine, Boston Children&#x2019;s Hospital</institution>, <addr-line>Boston</addr-line><addr-line>MA</addr-line>, <country>United States</country></aff><aff id="aff4"><institution>Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California Los Angeles</institution>, <addr-line>Los Angeles</addr-line><addr-line>CA</addr-line>, <country>United States</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Badawy</surname><given-names>Sherif</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name name-style="western"><surname>Allen</surname><given-names>Katie</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Kwon</surname><given-names>Misol</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Elissa R Weitzman, MSc, ScD<email>elissa.weitzman@childrens.harvard.edu</email></corresp></author-notes><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>6</day><month>12</month><year>2023</year></pub-date><volume>6</volume><elocation-id>e46555</elocation-id><history><date date-type="received"><day>30</day><month>03</month><year>2023</year></date><date date-type="rev-recd"><day>27</day><month>07</month><year>2023</year></date><date date-type="accepted"><day>15</day><month>08</month><year>2023</year></date></history><copyright-statement>&#x00A9; Elissa R Weitzman, Machiko Minegishi, Rachele Cox, Lauren E Wisk. Originally published in JMIR Pediatrics and Parenting (<ext-link ext-link-type="uri" xlink:href="https://pediatrics.jmir.org">https://pediatrics.jmir.org</ext-link>), 6.12.2023. </copyright-statement><copyright-year>2023</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Pediatrics and Parenting, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="https://pediatrics.jmir.org">https://pediatrics.jmir.org</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://pediatrics.jmir.org/2023/1/e46555"/><abstract><sec><title>Background</title><p>Social media data may augment understanding of the disease and treatment experiences and quality of life of youth with chronic medical conditions. Little is known about the willingness to share social media data for health research among youth with chronic medical conditions and the differences in health status between sharing and nonsharing youth with chronic medical conditions.</p></sec><sec><title>Objective</title><p>We aimed to evaluate the associations between patient-reported measures of disease symptoms and functioning and the willingness to share social media data.</p></sec><sec sec-type="methods"><title>Methods</title><p>Between February 2018 and August 2019, during routine clinic visits, survey data about social media use and the willingness to share social media data (dependent variable) were collected from adolescents in a national rheumatic disease registry. Survey data were analyzed with patient-reported measures of disease symptoms and functioning and a clinical measure of disease activity, which were collected through a parent study. We used descriptive statistics and multivariate logistic regression to compare patient-reported outcomes between youth with chronic medical conditions who opted to share social media data and those who did not opt to share such data.</p></sec><sec sec-type="results"><title>Results</title><p>Among 112 youths, (age: mean 16.1, SD 1.6 y; female: n=72, 64.3%), 83 (74.1%) agreed to share social media data. Female participants were more likely to share (<italic>P</italic>=.04). In all, 49 (43.8%) and 28 (25%) participants viewed and posted about rheumatic disease, respectively. Compared to nonsharers, sharers reported lower mobility (T-score: mean 49.0, SD 9.4 vs mean 53.9, SD 8.9; <italic>P</italic>=.02) and more pain interference (T-score: mean 45.7, SD 8.8 vs mean 40.4, SD 8.0; <italic>P</italic>=.005), fatigue (T-score: mean 49.1, SD 11.0 vs mean 39.7, SD 9.7; <italic>P</italic>&#x003C;.001), depression (T-score: mean 48.1, SD 8.9 vs mean 42.2, SD 8.4; <italic>P</italic>=.003), and anxiety (T-score: mean 45.2, SD 9.3 vs mean 38.5, SD 7.0; <italic>P</italic>&#x003C;.001). In regression analyses adjusted for age, sex, study site, and Physician Global Assessment score, each 1-unit increase in symptoms was associated with greater odds of willingness to share social media data, for measures of pain interference (Adjusted Odds Ratio [AOR] 1.07, 95% CI 1.001-1.14), fatigue (AOR 1.08, 95% CI 1.03-1.13), depression (AOR 1.07, 95% CI 1.01-1.13), and anxiety (AOR 1.10, 95% CI 1.03-1.18).</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>High percentages of youth with rheumatic diseases used and were willing to share their social media data for research. Sharers reported worse symptoms and functioning compared to those of nonsharers. Social media may offer a potent information source and engagement pathway for youth with rheumatic diseases, but differences between sharing and nonsharing youth merit consideration when designing studies and evaluating social media&#x2013;derived findings.</p></sec></abstract><kwd-group><kwd>patient-reported outcomes</kwd><kwd>PROM</kwd><kwd>outcome measure</kwd><kwd>outcome measures</kwd><kwd>patient reported</kwd><kwd>patient data</kwd><kwd>social media</kwd><kwd>sharing</kwd><kwd>personally generated data</kwd><kwd>chronic illness</kwd><kwd>quality of life</kwd><kwd>rheumatic disease</kwd><kwd>rheumatic</kwd><kwd>rheumatoid</kwd><kwd>adolescent</kwd><kwd>adolescents</kwd><kwd>youth</kwd><kwd>research involvement</kwd><kwd>privacy</kwd><kwd>confidentiality</kwd><kwd>confidential</kwd><kwd>personal</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Nearly 1 in 4 US youths are growing up with a chronic illness [<xref ref-type="bibr" rid="ref1">1</xref>]. Many experience significant levels of disease and treatment burden (eg, pain and medication side effects) that undermine well-being, leading to frequent and costly health care utilization and family financial problems [<xref ref-type="bibr" rid="ref2">2</xref>]. By adulthood, youth with a chronic illness face increased risks of poor educational, relationship, economic, and health outcomes [<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref4">4</xref>]. Life-course risks reflect the complex interplay of disease and treatment experiences and the cumulative effects of social isolation, victimization, school disruption, psychological injury, and home life strain that can accompany chronic illness [<xref ref-type="bibr" rid="ref5">5</xref>]. Capturing patients&#x2019; perspectives about these issues is vital to creating supportive interventions. This is especially true for adolescents, as the biopsychosocial processes of puberty, maturation, and development can impact the course and experience of chronic illness just as chronic illness experiences can impact these processes [<xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref>]. Patient-centered research with adolescents may advance understanding of these issues [<xref ref-type="bibr" rid="ref8">8</xref>-<xref ref-type="bibr" rid="ref10">10</xref>].</p><p>Psychosocial factors contribute to disease symptoms, such as pain and fatigue, among adolescents with a chronic illness [<xref ref-type="bibr" rid="ref11">11</xref>]. However, we do not know, with regard to the day-to-day lives of adolescents, what issues are the most important to address to disrupt feedback between disease activity and psychosocial health [<xref ref-type="bibr" rid="ref12">12</xref>-<xref ref-type="bibr" rid="ref14">14</xref>]. For example, the experience of pain may be exacerbated by feelings of stress and isolation related to a chronic illness, which can be missed by clinicians when making a treatment decision. Discordance between a young patient&#x2019;s disease experience, including their sense of well-being, and clinical manifestations of disease can stymie and misdirect treatment. This is important for chronic relapsing conditions that may have an unpredictable disease course with periods of flare and dormancy, such as pediatric-onset rheumatic diseases [<xref ref-type="bibr" rid="ref15">15</xref>-<xref ref-type="bibr" rid="ref18">18</xref>], which affect 1 in 250 US children younger than 18 years and account for an estimated US $8.3 billion in annual hospital charges [<xref ref-type="bibr" rid="ref19">19</xref>,<xref ref-type="bibr" rid="ref20">20</xref>]. Juvenile idiopathic arthritis (JIA) and systemic lupus erythematosus (SLE) are two common forms of pediatric-onset rheumatic disease. JIA is the most common cause of acquired disability in the United States and the fifth most common chronic childhood disease [<xref ref-type="bibr" rid="ref21">21</xref>]. Youth with JIA report poorer health-related quality of life than that of their peers, even in the setting of low disease activity and after treatment with biologic agents [<xref ref-type="bibr" rid="ref22">22</xref>-<xref ref-type="bibr" rid="ref24">24</xref>]. The impacts of JIA persist into adulthood, by which time nearly half of affected youth still experience recurrent or ongoing disease activity, active arthritis, progressive joint destruction, and decreased health-related quality of life [<xref ref-type="bibr" rid="ref22">22</xref>,<xref ref-type="bibr" rid="ref25">25</xref>-<xref ref-type="bibr" rid="ref28">28</xref>]. SLE is a lifelong, chronic, multisystem autoimmune disease; around 15% of persons with SLE developed it in childhood [<xref ref-type="bibr" rid="ref29">29</xref>], and these persons typically experience severe phenotypes, including organ disease. Youth with SLE may experience secondary morbidities and psychosocial difficulties (eg, mood disorders, body image problems, and academic and social challenges [<xref ref-type="bibr" rid="ref30">30</xref>]) because, in addition to life-threatening disease manifestations, treatment includes exposure to high doses and prolonged courses of glucocorticoids, as well as cytotoxic agents [<xref ref-type="bibr" rid="ref31">31</xref>-<xref ref-type="bibr" rid="ref33">33</xref>].</p><p>Patient-reported outcome (PRO) measures that capture dimensions of well-being can inform understanding of treatment experience and efficacy [<xref ref-type="bibr" rid="ref33">33</xref>], and studies on the clinical validity of PROs are underway among youth with rheumatic diseases and other conditions [<xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref33">33</xref>]. Data gleaned from youths&#x2019; social media use may serve as an additional source of information about young patients&#x2019; experiences of disease and treatment.</p><p>Engaging youth with JIA and SLE in reporting about their health via social media and in sharing their social media data with investigators may provide a channel for learning about youth psychosocial status and physical functioning to complement clinical observations and PROs. Social media data may be obtained passively or actively. In the passive case, social media data may be obtained without youths&#x2019; permission or even without their awareness (as when data are programmatically collected and even sold by social media platforms). Additionally, social media data may be obtained actively via approaches that involve permissioned sharing, opt-in settings, and explicit notifications [<xref ref-type="bibr" rid="ref34">34</xref>-<xref ref-type="bibr" rid="ref38">38</xref>].</p><p>Regulatory efforts are being enacted to protect the privacy and autonomy of youth in web-based spaces [<xref ref-type="bibr" rid="ref39">39</xref>,<xref ref-type="bibr" rid="ref40">40</xref>]. As such, it is vital to understand whether young cohorts are willing to actively share their social media data for health research and whether health status differs between sharing and nonsharing groups [<xref ref-type="bibr" rid="ref41">41</xref>]. Such insight would (1) clarify the feasibility of engaging youth with rheumatic diseases in sharing social media data for research and (2) help to quantify biases that could arise when relying on active models of collecting data from web-based cohorts. We sought to describe social media use among a clinically characterized cohort of youth with rheumatic diseases and to understand their passive (reading and viewing activities) and active (posting text or images) social media use in relation to these diseases. We further sought to quantify willingness to share social media data for health research and associations between willingness to share and patient-reported experiences of disease symptoms and functioning. We hypothesized that there would be equivalent percentages of youth who would and youth who would not agree to share their social media data for health research under a model of direct observation (ie, friending or otherwise providing access to social media data). Additionally, we hypothesized that the sharing cohort would report fewer symptoms and better functioning compared to those of the nonsharing cohort, potentially reflecting a greater sense of comfort and ease with their health and activities and fewer inhibitions about revealing any vulnerabilities. To date, few studies have been able to link personally generated data from social media with PROs and clinical data [<xref ref-type="bibr" rid="ref42">42</xref>] to elucidate biases relevant to establishing the validity of social media data for health research&#x2014;a recognized need [<xref ref-type="bibr" rid="ref43">43</xref>,<xref ref-type="bibr" rid="ref44">44</xref>].</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Overview</title><p>Among adolescents with JIA or SLE who were members of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry [<xref ref-type="bibr" rid="ref45">45</xref>,<xref ref-type="bibr" rid="ref46">46</xref>] and enrolled in a prospective multisite study to clinically validate PRO measures [<xref ref-type="bibr" rid="ref33">33</xref>], we investigated associations between social media use and willingness to share social media data for research. Survey reports were collected via a tablet computer by using the REDCap (Research Electronic Data Capture; Vanderbilt University) secure web application [<xref ref-type="bibr" rid="ref47">47</xref>,<xref ref-type="bibr" rid="ref48">48</xref>] at regularly scheduled clinics visits, during which PRO and clinical data were also collected.</p></sec><sec id="s2-2"><title>Ethical Considerations</title><p>A small stipend was provided to participants in the form of a US $20 gift card. Trained research assistants obtained in-person informed assent and assigned participants a unique study ID that was linked to the ID used for the clinical validation study and registry to ensure confidentiality. The study protocol was reviewed and approved by the Boston Children&#x2019;s Hospital institutional review board (protocol number: IRB-P00025665).</p></sec><sec id="s2-3"><title>Setting and Sample</title><p>Adolescents were eligible if they were members of the CARRA Registry, were diagnosed with JIA or SLE, enrolled in the parent prospective clinical validation study [<xref ref-type="bibr" rid="ref33">33</xref>], and were at 1 of 3 validation study sites that participated in this substudy. Additional eligibility criteria were an age of 13 to 18 years, the ability to complete the survey in English on a tablet computer, and the reported use of at least 1 of 4 popular social media platforms (Facebook, Twitter, Instagram, or Snapchat) in the past 30 days. Patients were ineligible if they were medically or emotionally unstable or were otherwise unable to assent, as determined by a clinician or site research team member; were unable to speak or read English at an eighth-grade reading level; or did not attend the data collection visit (absent at recruitment).</p><p>Of the 145 patients approached, 123 consented (84.8%), of whom 6 were excluded because they were absent during data collection or reported Patient-Reported Outcomes Measurement Information System (PROMIS) measures at a time that did not overlap social media data collection. Of the remaining 117 patients, 5 did not use Facebook, Twitter, Instagram, or Snapchat and were excluded, leaving an analytic sample of 112 (91.1%; <xref ref-type="fig" rid="figure1">Figure 1</xref>).</p><fig position="float" id="figure1"><label>Figure 1.</label><caption><p>CONSORT (Consolidated Standards of Reporting Trials) diagram of study sample.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="pediatrics_v6i1e46555_fig01.png"/></fig></sec><sec id="s2-4"><title>Sources of Study Data and Measures</title><p>Clinical and demographic data were drawn from the CARRA Registry. PRO and social media survey data were collected electronically by using wireless touch screen tablets during the clinic visit. Social demographic measures included race, Hispanic ethnicity, sex at birth, date of birth, insurance status, and the highest education attained by a parent. Clinical characteristics included the study recruitment and treatment site, the Physician Global Assessment (PGA) score [<xref ref-type="bibr" rid="ref49">49</xref>], a 10-point visual analog scale score (a value of &#x2265;1 represented active disease), BMI, and disease duration in months.</p><p>PROMIS Pediatric measures [<xref ref-type="bibr" rid="ref50">50</xref>,<xref ref-type="bibr" rid="ref51">51</xref>] included short-form measures of fatigue, mobility, pain interference, depressive symptoms, anxiety, and meaning and purpose, which were administered by using computer-assisted technology [<xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref33">33</xref>]. Higher PROMIS symptom T-scores reflect worse symptom levels, and higher functioning scores reflect better functioning. PROMIS measures are designed such that the mean score of the relevant reference population (ie, healthy youth) is 50, with an SD of 10 [<xref ref-type="bibr" rid="ref52">52</xref>]. A 3-point difference in the PROMIS Pediatric T-score metric is considered a minimally important difference [<xref ref-type="bibr" rid="ref53">53</xref>].</p><p>Willingness to share social media data via direct observation by the research team was assessed for Facebook, Instagram, Twitter, and Snapchat. Willingness measures are summarized in <xref ref-type="table" rid="table1">Table 1</xref>, along with related measures of motivation to share social media data, reasons for not sharing, and passive and active use patterns.</p><table-wrap id="t1" position="float"><label>Table 1.</label><caption><p>Measures of willingness to share social media data.</p></caption><table id="table1" frame="hsides" rules="groups"><thead><tr><td align="left" valign="top" colspan="2">Question</td><td align="left" valign="top">Response options</td><td align="left" valign="top">Answers</td></tr></thead><tbody><tr><td align="left" valign="top" colspan="4"><bold>Willingness to share social media</bold></td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">&#x201C;Are you willing to share your social media posts from the following site(s) for the two-week time interval around this study visit and your next study visit? This involves &#x2018;friending&#x2019; the study account so the study team can view your posts. We will not message, &#x2018;like,&#x2019; post on, or interact with your accounts&#x201D;</td><td align="left" valign="top"><list list-type="bullet"><list-item><p>Facebook</p></list-item><list-item><p>Twitter</p></list-item><list-item><p>Instagram</p></list-item><list-item><p>Snapchat</p></list-item></list></td><td align="left" valign="top"><list list-type="order"><list-item><p>Yes</p></list-item><list-item><p>No</p></list-item><list-item><p>Prefer not to answer</p></list-item></list></td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">&#x201C;(If YES to sharing any SM with the study) How much do you agree with the following statements regarding your motivations for sharing your social media data with this study?&#x201D;</td><td align="left" valign="top"><list list-type="bullet"><list-item><p>I will be able to help other patients with rheumatic conditions</p></list-item><list-item><p>I am interested in research</p></list-item><list-item><p>I am interested in social media and technology</p></list-item><list-item><p>Participating in this research makes me feel valued</p></list-item><list-item><p>The $20<sup><xref ref-type="table-fn" rid="table1fn1">a</xref></sup> gift card incentivized me to participate in this research</p></list-item><list-item><p>I have some other motivation for sharing my social media data with this study</p></list-item></list></td><td align="left" valign="top"><list list-type="order"><list-item><p>Strongly agree</p></list-item><list-item><p>Agree</p></list-item><list-item><p>Disagree</p></list-item><list-item><p>Strongly disagree</p></list-item><list-item><p>Prefer not to answer</p></list-item></list></td></tr><tr><td align="left" valign="top" colspan="4"><bold>Frequency of social media use</bold></td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">&#x201C;About how often do you visit OR use the following social media sites?&#x201D;</td><td align="left" valign="top"><list list-type="bullet"><list-item><p>Facebook</p></list-item><list-item><p>Twitter</p></list-item><list-item><p>Instagram</p></list-item><list-item><p>Snapchat</p></list-item></list></td><td align="left" valign="top"><list list-type="order"><list-item><p>Several times a day</p></list-item><list-item><p>About once a day</p></list-item><list-item><p>A few times a week</p></list-item><list-item><p>Every few weeks</p></list-item><list-item><p>Less often</p></list-item><list-item><p>I do not use this site</p></list-item><list-item><p>Prefer not to answer</p></list-item></list></td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top">&#x201C;How often do you VIEW/READ about other people who have a rheumatic condition on any of the following sites?&#x201D;</td><td align="left" valign="top"><list list-type="bullet"><list-item><p>Facebook</p></list-item><list-item><p>Twitter</p></list-item><list-item><p>Instagram</p></list-item><list-item><p>Snapchat</p></list-item></list></td><td align="left" valign="top"><list list-type="order"><list-item><p>Often</p></list-item><list-item><p>Sometimes</p></list-item><list-item><p>Rarely</p></list-item><list-item><p>Never</p></list-item><list-item><p>Prefer not to answer</p></list-item></list></td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top">&#x201C;Have you ever POSTED about your rheumatic condition on social media?&#x201D;</td><td align="left" valign="top"><list list-type="bullet"><list-item><p>N/A<sup><xref ref-type="table-fn" rid="table1fn2">b</xref></sup></p></list-item></list></td><td align="left" valign="top"><list list-type="order"><list-item><p>Yes</p></list-item><list-item><p>No</p></list-item><list-item><p>Prefer not to answer</p></list-item></list></td></tr><tr><td align="left" valign="top" colspan="4"><bold>Benefits of viewing/reading about others with RD<sup><xref ref-type="table-fn" rid="table1fn3">c</xref></sup></bold></td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">&#x201C;VIEWING/READING about other people who have a rheumatic condition on social media&#x2026;&#x201D;</td><td align="left" valign="top"><list list-type="bullet"><list-item><p>Helps me to feel less alone with my rheumatic condition</p></list-item><list-item><p>Helps me to talk to my friends about my rheumatic condition</p></list-item><list-item><p>Helps me to feel more prepared when talking to my doctor/care team about my rheumatic condition</p></list-item><list-item><p>Provides me with information about my condition that I can understand</p></list-item><list-item><p>Helps me to talk to my parents or guardians about my rheumatic condition</p></list-item><list-item><p>Provides me with information about treatments for my rheumatic condition</p></list-item><list-item><p>Provides me with health information that my doctors/care team cannot provide</p></list-item><list-item><p>Provides me with health information that I cannot find anywhere else</p></list-item></list></td><td align="left" valign="top"><list list-type="order"><list-item><p>Strongly agree</p></list-item><list-item><p>Agree</p></list-item><list-item><p>Disagree</p></list-item><list-item><p>Strongly disagree</p></list-item><list-item><p>Prefer not to answer</p></list-item></list></td></tr><tr><td align="left" valign="top" colspan="4"><bold>Motivations for posting</bold></td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">&#x201C;How much do the following reasons motivate you to POST/SHARE about your condition on social media?&#x201D;</td><td align="left" valign="top"><list list-type="bullet"><list-item><p>I want to feel understood</p></list-item><list-item><p>I want to help or provide support to other people living with a rheumatic condition or any chronic health condition</p></list-item><list-item><p>I want to connect with others living with a rheumatic condition or any chronic health condition</p></list-item><list-item><p>I want to share my experiences with a community that believes me</p></list-item><list-item><p>I want to update my friends/family members about my rheumatic condition</p></list-item><list-item><p>I want to get help or support from others who are living with a rheumatic condition or any chronic health condition</p></list-item><list-item><p>I want to share my thoughts/feelings when my rheumatic condition is under good control</p></list-item><list-item><p>I want to share my thoughts/feelings when I am experiencing disease symptoms</p></list-item></list></td><td align="left" valign="top"><list list-type="order"><list-item><p>A great deal</p></list-item><list-item><p>Somewhat</p></list-item><list-item><p>Very little</p></list-item><list-item><p>Not at all</p></list-item><list-item><p>Prefer not to answer</p></list-item></list></td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">&#x201C;How important to you are the following reasons when you are making decisions NOT to POST/SHARE about your rheumatic condition?&#x201D;</td><td align="left" valign="top"><list list-type="bullet"><list-item><p>My rheumatic condition does not define me</p></list-item><list-item><p>I do not want others to feel bad for me because of my rheumatic condition</p></list-item><list-item><p>I do not want to disclose my diagnosis public on the internet</p></list-item><list-item><p>My rheumatic condition is not serious enough for me to post about it on social media</p></list-item><list-item><p>I worry about others knowing too much about my health</p></list-item><list-item><p>I do not want my friends to find out how I am feeling or doing</p></list-item><list-item><p>People might make fun of me, or I might get teased/bullied</p></list-item><list-item><p>I do not want my parents or guardians to find out how I am feeling or doing</p></list-item></list></td><td align="left" valign="top"><list list-type="order"><list-item><p>A great deal</p></list-item><list-item><p>Somewhat</p></list-item><list-item><p>Very little</p></list-item><list-item><p>Not at all</p></list-item><list-item><p>Prefer not to answer</p></list-item></list></td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><p><sup>a</sup>US $20.</p></fn><fn id="table1fn2"><p><sup>b</sup>N/A: not applicable.</p></fn><fn id="table1fn3"><p><sup>c</sup>RD: rheumatic disease.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-5"><title>Data Analyses</title><p>Summary statistics were computed to characterize the study sample overall and by willingness to share social media data for research. The differences in demographic characteristics based on willingness to share social media data were analyzed by using appropriate statistical tests, including the Kruskal-Wallis test, 2-tailed <italic>t</italic> test, 2-sided Fisher exact test, and chi-square test. For 2 participants with JIA and 1 patient with SLE, we imputed missing values on the PGA by using the median score for their disease group and similarly imputed missing BMI values for 2 participants with JIA. In separate multivariable logistic regressions, we assessed the associations between willingness to share social media data for research (the dependent variable) and each PROMIS measure. All models controlled for age, biological sex, study site, and PGA score. The analyses were conducted by using SAS 9.4 (SAS Institute) [<xref ref-type="bibr" rid="ref54">54</xref>]. Statistical significance was considered at <italic>P</italic>&#x003C;.05.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><sec id="s3-1"><title>Sample Characteristics</title><p>Of the 112 participants, 98 (87.5%) were persons with JIA and 14 (12.5%) were persons with SLE. Overall, participants were aged 13 to 18 (mean 16.1, SD 1.6) years, 72 (64.3%) were female, 86 (76.8%) were White, 105 (93.8%) were non-Hispanic, and 101 (90.2%) had private insurance. For all, the average BMI was 23.2 (SD 4.3) kg/m<sup>2</sup>, and the average PGA score was 0.8 (SD 1.5), indicating inactive disease.</p><p>Willingness to share social media data was reported by a majority (83/112, 74.1%) of participants. In all, 43.8% (49/112) reported viewing or reading about others with rheumatic diseases on social media, and 25% (28/112) reported posting about rheumatic disease (<xref ref-type="table" rid="table1">Table 1</xref>).</p></sec><sec id="s3-2"><title>Association Between Willingness to Share Social Media Data and Health Status</title><p>Willingness to share social media data was associated with female sex (<italic>P</italic>=.04) and greater disease activity (<italic>P</italic>=.04), which was measured as a mean PGA score (<xref ref-type="table" rid="table2">Table 2</xref>). Compared to nonsharers, sharers reported lower mobility (T-score: mean 49.0, SD 9.4 vs mean 53.9, SD 8.9; <italic>P</italic>=.02), greater pain interference (T-score: mean 45.7, SD 8.8 vs mean 40.4, SD 8.0; <italic>P</italic>=.005), more fatigue (T-score: mean 49.1, SD 11.0 vs mean 39.7, SD 9.7; <italic>P</italic>&#x003C;.001), more depression (T-score: mean 48.1, SD 8.9 vs mean 42.2, SD 8.4; <italic>P</italic>=.003), and greater anxiety (T-score: mean 45.2, SD 9.3 vs mean 38.5, SD 7.0; <italic>P</italic>&#x003C;.001).</p><p>In logistic regression analyses that controlled for age, sex, study site, and PGA score, each 1-unit increase in symptoms was associated with greater odds of willingness to share social media data, for measures of pain interference (Adjusted Odds Ratio [AOR] 1.07, 95% CI 1.001-1.14), fatigue (AOR 1.08, 95% CI 1.03-1.13), depression (AOR 1.07, 95% CI 1.01-1.13), and anxiety (AOR 1.10, 95% CI 1.03-1.18; <xref ref-type="table" rid="table3">Table 3</xref>).</p><table-wrap id="t2" position="float"><label>Table 2.</label><caption><p>Characteristics of the sample by willingness to share social media.</p></caption><table id="table2" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom" colspan="3">Characteristics</td><td align="left" valign="bottom">All participants (N=112)</td><td align="left" valign="bottom" colspan="2">Social media sharing</td><td align="left" valign="bottom"><italic>P</italic> value</td></tr><tr><td align="left" valign="bottom" colspan="3"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Yes (n=83, 74.1%)</td><td align="left" valign="bottom">No (n=29, 25.9%)</td><td align="left" valign="bottom"/></tr></thead><tbody><tr><td align="left" valign="top" colspan="3">Age (years), mean (SD)</td><td align="left" valign="top">16.1 (1.6)</td><td align="left" valign="top">16.2 (1.6)</td><td align="left" valign="top">15.9 (1.5)</td><td align="left" valign="top">.34</td></tr><tr><td align="left" valign="top" colspan="6"><bold>Biological sex, n (%<sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup>)</bold></td><td align="left" valign="top">.04</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Male</td><td align="left" valign="top">40 (35.7)</td><td align="left" valign="top">25 (30.1)</td><td align="left" valign="top">15 (51.7)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Female</td><td align="left" valign="top">72 (64.3)</td><td align="left" valign="top">58 (69.9)</td><td align="left" valign="top">14 (48.3)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="6"><bold>Race, n (%<sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup>)</bold></td><td align="left" valign="top">.51</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">White</td><td align="left" valign="top">86 (76.7)</td><td align="left" valign="top">65 (78.3)</td><td align="left" valign="top">21 (72.4)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Asian</td><td align="left" valign="top">5 (4.5)</td><td align="left" valign="top">2 (2.4)</td><td align="left" valign="top">3 (10.3)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">African American</td><td align="left" valign="top">2 (1.8)</td><td align="left" valign="top">2 (2.4)</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Mixed race</td><td align="left" valign="top">4 (3.6)</td><td align="left" valign="top">3 (4.6)</td><td align="left" valign="top">1 (3.4)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Other race<sup><xref ref-type="table-fn" rid="table2fn2">b</xref></sup></td><td align="left" valign="top">6 (5.4)</td><td align="left" valign="top">5 (6)</td><td align="left" valign="top">1 (3.4)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Unknown</td><td align="left" valign="top">9 (8)</td><td align="left" valign="top">6 (7.2)</td><td align="left" valign="top">3 (10.3)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="6"><bold>Ethnicity, n (%<sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup>)</bold></td><td align="left" valign="top">.67</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Hispanic</td><td align="left" valign="top">7 (6.3)</td><td align="left" valign="top">6 (7.2)</td><td align="left" valign="top">1 (3.4)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Non-Hispanic</td><td align="left" valign="top">105 (93.8)</td><td align="left" valign="top">77 (92.8)</td><td align="left" valign="top">28 (96.6)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="6"><bold>Parental education, n (%<sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup>)</bold></td><td align="left" valign="top">.10</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Less than a college degree</td><td align="left" valign="top">2 (1.8)</td><td align="left" valign="top">0 (0)</td><td align="left" valign="top">2 (6.9)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">College degree or higher</td><td align="left" valign="top">39 (34.8)</td><td align="left" valign="top">29 (34.9)</td><td align="left" valign="top">10 (34.5)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Prefer not to answer or missing</td><td align="left" valign="top">71 (63.4)</td><td align="left" valign="top">54 (65.1)</td><td align="left" valign="top">17 (58.6)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="6"><bold>Insurance, n (%<sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup>)</bold></td><td align="left" valign="top">.15</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Private health insurance</td><td align="left" valign="top">101 (90.2)</td><td align="left" valign="top">77 (92.8)</td><td align="left" valign="top">24 (82.8)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Government insurance or other</td><td align="left" valign="top">11 (9.8)</td><td align="left" valign="top">6 (7.2)</td><td align="left" valign="top">5 (17.2)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="6"><bold>Rheumatic disease diagnosis, n (%<sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup>)</bold></td><td align="left" valign="top">.19</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Systemic lupus erythematosus</td><td align="left" valign="top">14 (12.5)</td><td align="left" valign="top">8 (9.6)</td><td align="left" valign="top">6 (20.6)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Juvenile idiopathic arthritis</td><td align="left" valign="top">98 (87.5)</td><td align="left" valign="top">75 (90.4)</td><td align="left" valign="top">23 (79.3)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top" colspan="7"><bold>Health characteristics, mean (SD)</bold></td></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">BMI (kg/m<sup>2</sup>)</td><td align="left" valign="top">23.2 (4.3)</td><td align="left" valign="top">23.3 (4.3)</td><td align="left" valign="top">22.7 (4.6)</td><td align="left" valign="top">.39</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Disease duration (months)</td><td align="left" valign="top">84.6 (53.8)</td><td align="left" valign="top">84.2 (52.9)</td><td align="left" valign="top">85.6 (57.1)</td><td align="left" valign="top">&#x003E;.99</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Physician Global Assessment (score)</td><td align="left" valign="top">0.8 (1.5)</td><td align="left" valign="top">1.0 (1.6)</td><td align="left" valign="top">0.5 (1.1)</td><td align="left" valign="top">.04</td></tr><tr><td align="left" valign="top" colspan="7"><bold>PROMIS</bold><sup><xref ref-type="table-fn" rid="table2fn3"><bold>c</bold></xref></sup> <bold>Pediatric measure (T-score)</bold></td></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Mobility</td><td align="left" valign="top">50.3 (9.5)</td><td align="left" valign="top">49.0 (9.4)</td><td align="left" valign="top">53.9 (8.9)</td><td align="left" valign="top">.02</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Pain interference</td><td align="left" valign="top">44.3 (8.9)</td><td align="left" valign="top">45.7 (8.8)</td><td align="left" valign="top">40.4 (8.0)</td><td align="left" valign="top">.005</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Fatigue</td><td align="left" valign="top">46.7 (11.4)</td><td align="left" valign="top">49.1 (11.0)</td><td align="left" valign="top">39.7 (9.7)</td><td align="left" valign="top">&#x003C;.001</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Depressive symptoms</td><td align="left" valign="top">46.6 (9.1)</td><td align="left" valign="top">48.1 (8.9)</td><td align="left" valign="top">42.2 (8.4)</td><td align="left" valign="top">.003</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Anxiety</td><td align="left" valign="top">43.5 (9.2)</td><td align="left" valign="top">45.2 (9.3)</td><td align="left" valign="top">38.5 (7.0)</td><td align="left" valign="top">&#x003C;.001</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top" colspan="2">Meaning and purpose<sup><xref ref-type="table-fn" rid="table2fn4">d</xref></sup></td><td align="left" valign="top">47.4 (8.3)</td><td align="left" valign="top">47.4 (8.6)</td><td align="left" valign="top">47.2 (7.4)</td><td align="left" valign="top">.91</td></tr><tr><td align="left" valign="top" colspan="3">Passive social media use, n (%<sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup>)</td><td align="left" valign="top">49 (43.8)</td><td align="left" valign="top">39 (47)</td><td align="left" valign="top">10 (34.5)</td><td align="left" valign="top">.24</td></tr><tr><td align="left" valign="top" colspan="3">Active social media use, n (%<sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup>)</td><td align="left" valign="top">28 (25)</td><td align="left" valign="top">23 (27.7)</td><td align="left" valign="top">5 (17.2)</td><td align="left" valign="top">.26</td></tr></tbody></table><table-wrap-foot><fn id="table2fn1"><p><sup>a</sup>Column percentages are shown (ie, the percentages were calculated by using the n values presented in the &#x201C;All Participants&#x201D; [N=112], &#x201C;Yes&#x201D; [n=83], and &#x201C;No&#x201D; [n=29] headings as the denominators).</p></fn><fn id="table2fn2"><p><sup>b</sup>Includes Middle Eastern or North African, Native American, American Indian, Alaska Native, Native Hawaiian, or other Pacific Islander.</p></fn><fn id="table2fn3"><p><sup>c</sup>PROMIS: Patient-Reported Outcomes Measurement Information System.</p></fn><fn id="table2fn4"><p><sup>d</sup>PROMIS measures for meaning and purpose were assessed among a total of 105 participants, including 80 (76.2%) in the &#x201C;Yes&#x201D; social media sharing group. Out of 112 total participants, 7 were not administered the PROMIS Meaning and Purpose survey during the parent study visit for reasons of timing.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3" position="float"><label>Table 3.</label><caption><p>Associations between PROMIS<sup><xref ref-type="table-fn" rid="table3fn1">a</xref></sup> Pediatric measures of physical functioning, symptoms, and psychosocial well-being and social media sharing (N=112).<sup><xref ref-type="table-fn" rid="table3fn2">b</xref></sup></p></caption><table id="table3" frame="hsides" rules="groups"><thead><tr><td align="left" valign="top">PROMIS Pediatric measure</td><td align="left" valign="top" colspan="2">Adjusted odds ratio<sup><xref ref-type="table-fn" rid="table3fn3">c</xref></sup> (95% CI)</td></tr></thead><tbody><tr><td align="left" valign="top">Mobility</td><td align="left" valign="top" colspan="2">0.95 (0.89-1.003)</td></tr><tr><td align="left" valign="top">Pain inference</td><td align="left" valign="top" colspan="2">1.07 (1.001-1.14)</td></tr><tr><td align="left" valign="top">Fatigue</td><td align="left" valign="top" colspan="2">1.08 (1.03-1.13)</td></tr><tr><td align="left" valign="top">Depressive symptoms</td><td align="left" valign="top" colspan="2">1.07 (1.01-1.13)</td></tr><tr><td align="left" valign="top">Anxiety</td><td align="left" valign="top" colspan="2">1.10 (1.03-1.18)</td></tr><tr><td align="left" valign="top">Meaning and purpose<sup><xref ref-type="table-fn" rid="table3fn4">d</xref></sup></td><td align="left" valign="top" colspan="2">1.01 (0.95-1.07)</td></tr></tbody></table><table-wrap-foot><fn id="table3fn1"><p><sup>a</sup>PROMIS: Patient-Reported Outcomes Measurement Information System.</p></fn><fn id="table3fn2"><p><sup>b</sup>Outcome: sharing social media contents (reference: not sharing social media); exposure: 1-unit increase in the PROMIS.</p></fn><fn id="table3fn3"><p><sup>c</sup>Adjusted models controlled for the participants&#x2019; age, sex, study sites, and Physician Global Assessment score. The reference group for the model is the participant group that was not willing to share the contents of any of their social media platforms with the researchers for this study. For each model, each individual PROMIS measure was entered independently, so these estimates do not reflect adjustment for other PROMIS measures.</p></fn><fn id="table3fn4"><p><sup>d</sup>PROMIS measures for meaning and purpose were assessed among a total of 105 participants, including 80 (76.2%) in the &#x201C;Yes&#x201D; social media sharing group. Out of 112 total participants, 7 were not administered the PROMIS Meaning and Purpose survey during the parent study visit for reasons of timing.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3-3"><title>Social Media Use and Value for Youth With Rheumatic Disease</title><p>The use of Instagram, Snapchat, Facebook, and Twitter was reported by 94.6% (106/112), 83.9% (94/112), 42.9% (48/112), and 31.3% (35/112) of participants, respectively, and poly-platform use was reported by 84.8% (95/112) of participants. More than two-fifths of participants (49/112, 43.8%) reported passive social media use, that is, reading about others with rheumatic diseases, while one-quarter (28/112, 25%) reported active social media use, that is, posting about rheumatic disease. Passive and active use patterns did not differ by age or by diagnosis; however, larger percentages of female participants than male participants reported both passive and active rheumatic disease&#x2013;related social media activity (<xref ref-type="table" rid="table4">Table 4</xref>).</p><table-wrap id="t4" position="float"><label>Table 4.</label><caption><p>Sample characteristics by passive or active social media use.</p></caption><table id="table4" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom" colspan="2">Characteristics</td><td align="left" valign="bottom">All participants (N=112)</td><td align="left" valign="bottom" colspan="3">Read about others with RD<sup><xref ref-type="table-fn" rid="table4fn1">a</xref></sup> on SM<sup><xref ref-type="table-fn" rid="table4fn2">b</xref></sup></td><td align="left" valign="bottom" colspan="3">Post about RD on SM</td></tr><tr><td align="left" valign="bottom" colspan="2"/><td align="left" valign="bottom"/><td align="left" valign="bottom">Yes (n=49, 43.8%)</td><td align="left" valign="bottom">No (n=63, 56.3%)</td><td align="left" valign="bottom"><italic>P</italic> value</td><td align="left" valign="bottom">Yes (n=28, 25%)</td><td align="left" valign="bottom">No (n=84, 75%)</td><td align="left" valign="bottom"><italic>P</italic> value</td></tr></thead><tbody><tr><td align="left" valign="top" colspan="2">Age (years), mean (SD)</td><td align="left" valign="top">16.1 (1.6)</td><td align="left" valign="top">16.3 (1.6)</td><td align="left" valign="top">16.0 (1.6)</td><td align="left" valign="top">.32</td><td align="left" valign="top">16.3 (1.6)</td><td align="left" valign="top">16.1 (1.6)</td><td align="left" valign="top">.61</td></tr><tr><td align="left" valign="top" colspan="9"><bold>Biological sex, n (%)</bold></td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Male</td><td align="left" valign="top">40 (35.7<sup><xref ref-type="table-fn" rid="table4fn3">c</xref></sup>)</td><td align="left" valign="top">9 (22.5<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup>)</td><td align="left" valign="top">31 (77.5<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup>)</td><td align="left" valign="top">&#x003C;.001</td><td align="left" valign="top">2 (5<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup>)</td><td align="left" valign="top">38 (95<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup>)</td><td align="left" valign="top">&#x003C;.001</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Female</td><td align="left" valign="top">72 (64.3<sup><xref ref-type="table-fn" rid="table4fn3">c</xref></sup>)</td><td align="left" valign="top">40 (55.6<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup>)</td><td align="left" valign="top">32 (44.4<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup>)</td><td align="left" valign="top">N/A<sup><xref ref-type="table-fn" rid="table4fn5">e</xref></sup></td><td align="left" valign="top">26 (36.1<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup>)</td><td align="left" valign="top">46 (63.9<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup>)</td><td align="left" valign="top">N/A</td></tr><tr><td align="left" valign="top" colspan="9"><bold>Rheumatic disease diagnosis, n (%)</bold></td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Systemic lupus erythematosus</td><td align="left" valign="top">14 (12.5<sup><xref ref-type="table-fn" rid="table4fn3">c</xref></sup>)</td><td align="left" valign="top">9 (64.3<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup>)</td><td align="left" valign="top">5 (35.7<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup>)</td><td align="left" valign="top">.10</td><td align="left" valign="top">5 (35.7<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup>)</td><td align="left" valign="top">9 (64.3<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup>)</td><td align="left" valign="top">.33</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top">Juvenile idiopathic arthritis</td><td align="left" valign="top">98 (87.5<sup><xref ref-type="table-fn" rid="table4fn3">c</xref></sup>)</td><td align="left" valign="top">40 (40.8<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup>)</td><td align="left" valign="top">58 (59.2<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup>)</td><td align="left" valign="top">N/A</td><td align="left" valign="top">23 (23.5<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup>)</td><td align="left" valign="top">75 (76.5<sup><xref ref-type="table-fn" rid="table4fn4">d</xref></sup>)</td><td align="left" valign="top">N/A</td></tr><tr><td align="left" valign="top" colspan="2">BMI (kg/m<sup>2</sup>), mean (SD)</td><td align="left" valign="top">23.2 (4.3)</td><td align="left" valign="top">23.3 (4.3)</td><td align="left" valign="top">23.0 (4.4)</td><td align="left" valign="top">.78</td><td align="left" valign="top">24.4 (4.8)</td><td align="left" valign="top">22.7 (4.1)</td><td align="left" valign="top">.12</td></tr><tr><td align="left" valign="top" colspan="2">Disease duration (months), mean (SD)</td><td align="left" valign="top">84.6 (53.8)</td><td align="left" valign="top">76.9 (49.2)</td><td align="left" valign="top">90.5 (56.7)</td><td align="left" valign="top">.21</td><td align="left" valign="top">83.2 (48.7)</td><td align="left" valign="top">85.0 (55.6)</td><td align="left" valign="top">.96</td></tr><tr><td align="left" valign="top" colspan="2">Physical Global Assessment (score), mean (SD)</td><td align="left" valign="top">0.8 (1.5)</td><td align="left" valign="top">0.8 (1.2)</td><td align="left" valign="top">0.8 (1.7)</td><td align="left" valign="top">.23</td><td align="left" valign="top">0.6 (0.7)</td><td align="left" valign="top">0.9 (1.6)</td><td align="left" valign="top">.99</td></tr></tbody></table><table-wrap-foot><fn id="table4fn1"><p><sup>a</sup>RD: rheumatic disease.</p></fn><fn id="table4fn2"><p><sup>b</sup>SM: social media.</p></fn><fn id="table4fn3"><p><sup>c</sup>This percentage was calculated by using the total number of participants (N=112) as the denominator.</p></fn><fn id="table4fn4"><p><sup>d</sup>A row percentage is presented (ie, the n value in the corresponding &#x201C;All Participants&#x201D; row total was used as the denominator).</p></fn><fn id="table4fn5"><p><sup>e</sup>N/A: not applicable.</p></fn></table-wrap-foot></table-wrap><p>Among 49 youths who reported passive disease-related use of social media, there were high levels of agreement that such use is helpful for observational learning from others and for alleviating feelings of isolation (<xref ref-type="fig" rid="figure2">Figure 2</xref>). Similarly, many reported that passive use increases their access to understandable information and helps them feel prepared in speaking with family and their care team about rheumatic disease. Of the 28 social media users who reported that they use social media actively to post about rheumatic disease, many reported doing so to feel understood, support and connect with others with rheumatic diseases, and share experiences with family and the rheumatic disease community (<xref ref-type="fig" rid="figure3">Figure 3</xref>). Among all social media users, a plurality endorsed the importance of not defining themselves by their condition and not wanting others to feel badly for them because of their condition, reporting these as reasons for <italic>not</italic> posting about their condition. Others refrained from posting about their condition to avoid public disclosure, retain privacy, and protect themselves from others&#x2019; attention or because they considered their condition insufficiently serious to merit attention (<xref ref-type="fig" rid="figure4">Figure 4</xref>). Finally, participants who shared their social media data reported they were motivated to do so because they were interested in research or technology, out of altruism toward other patients with the same conditions, to feel valued, and to receive a stipend (<xref ref-type="fig" rid="figure5">Figure 5</xref>).</p><fig position="float" id="figure2"><label>Figure 2.</label><caption><p>Responses for the following measure: &#x201C;VIEWING/READING about other people who have a rheumatic condition on social media.&#x201D; RD: rheumatic disease.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="pediatrics_v6i1e46555_fig02.png"/></fig><fig position="float" id="figure3"><label>Figure 3.</label><caption><p>Responses for the following measure: &#x201C;How much do the following reasons motivate you to POST/SHARE about your condition on social media?&#x201D; RD: rheumatic disease.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="pediatrics_v6i1e46555_fig03.png"/></fig><fig position="float" id="figure4"><label>Figure 4.</label><caption><p>Responses to the following measure: &#x201C;How important to you are the following reasons when you are making decisions NOT to POST/SHARE about your rheumatic condition?&#x201D; RD: rheumatic disease.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="pediatrics_v6i1e46555_fig04.png"/></fig><fig position="float" id="figure5"><label>Figure 5.</label><caption><p>Responses to the following measure: &#x201C;How much do you agree with the following statements regarding your motivations for sharing your social media data with this study?&#x201D; RD: rheumatic disease.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="pediatrics_v6i1e46555_fig05.png"/></fig></sec></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><sec id="s4-1"><title>Principal Findings</title><p>In this multisite cohort study centered on adolescents with rheumatic diseases, we found high levels of willingness to share social media data for health research. Contrary to our original hypothesis that willingness to share would be associated with lower levels of symptoms and better psychosocial status, sharing was associated with higher levels of disease-related symptoms, specifically pain interference and fatigue, and higher levels of depression and anxiety. Both passive and active disease-related use of social media were reported, and larger percentages of female participants than male participants engaged in these activities. Passive and active social media use patterns were motivated by participants&#x2019; goals regarding observational learning about their condition and connection to others with similar conditions, as well as by the exchange of social support. Motivations to refrain from posting about rheumatic disease reflected participants&#x2019; goals of wanting to avoid having their condition define them, remaining private, and protecting against disclosure and ridicule. Among participants who agreed to share their social media data for research (n=83), almost all did so out of interest in research (83/83, 100%), to help others with a rheumatic condition (80/83, 96%), and because they felt it was of value personally (70/83, 84%) and financially (ie, for compensation; 59/83, 71%).</p><p>A growing body of research indicates the potential for improving adolescent and young adult health behaviors and outcomes (eg, health food consumption, reduced BMI, and reduced tobacco use) through engagement with social media and related features for peer groups and messaging [<xref ref-type="bibr" rid="ref55">55</xref>-<xref ref-type="bibr" rid="ref57">57</xref>]. Nevertheless, understanding of the potential for using social media as a source of health information and as a platform for research engagement is constrained by the lack of insight into the differences in health status between persons who are and persons who are not willing to share their data. For participatory surveillance models, some evidence shows that greater sharing and openness exist among early adopters of research apps and among persons whose disease is better controlled [<xref ref-type="bibr" rid="ref58">58</xref>]. Other studies have found less reticence to share digital health data for care improvement among technology users who report lower incomes when compared to those who report higher incomes [<xref ref-type="bibr" rid="ref59">59</xref>].</p><p>This study adds to what is known about willingness to share social media, with the added advantage of assessing reports from a clinically characterized cohort whose actual sharing was directly observed, differing from studies on hypothetical willingness, which are more common [<xref ref-type="bibr" rid="ref60">60</xref>-<xref ref-type="bibr" rid="ref62">62</xref>]. Few studies of social media use and social media data sharing provide access to linked clinical data [<xref ref-type="bibr" rid="ref42">42</xref>] or structured PROs, and to our knowledge, none have been undertaken among youth with rheumatic diseases. Research with teenagers is vital, since this group is assuming control over their own health care, health information, and social media, and as a group, teenagers are both heavily engaged with social media [<xref ref-type="bibr" rid="ref63">63</xref>] and uniquely vulnerable to social influences communicated through web-based channels [<xref ref-type="bibr" rid="ref58">58</xref>,<xref ref-type="bibr" rid="ref59">59</xref>,<xref ref-type="bibr" rid="ref64">64</xref>,<xref ref-type="bibr" rid="ref65">65</xref>].</p><p>Our findings of differences between sharing and nonsharing cohorts have implications for the use of personally generated data from web-based cohorts. In this study, sharing was associated with worse health. It is not clear what explains differences in health status between sharing and nonsharing youth. It may be that youth with rheumatic diseases who are unwilling to share their social media data are more socially engaged in ways that they consider unsuitable or too sensitive to allow sharing. Alternatively, they may be less desirous of research attention if they feel well and are able to satisfy their social needs through offline means. Future work may help elucidate reasons for observed differences. Similarly, future work with youth affected by other conditions is merited to understand whether differences between sharing and nonsharing groups hold.</p><p>The findings from this study have larger implications for social media&#x2013;related research. First, investigators who use social media platforms to engage adolescents in health research should be explicit about the potential for biases related to inferences when denominators are poorly specified or are unknown [<xref ref-type="bibr" rid="ref41">41</xref>,<xref ref-type="bibr" rid="ref66">66</xref>]. The results from this study suggest that observations about the health of youth with rheumatic diseases drawn from social media&#x2013;engaged cohorts may be skewed toward describing youth with greater symptoms and worse psychosocial health. This is a limitation when the goal of a study is to understand the entirety of a patient population but may be an advantage when the aim of a study is to engage youth who are struggling. The internet and social media serve important supportive functions for youth with a chronic illness, of whom many have been disproportionately adversely affected by social isolation and the hardships of the recent COVID-19 pandemic [<xref ref-type="bibr" rid="ref67">67</xref>]. Second, findings regarding the high value placed by youth with rheumatic diseases on obtaining social and informational support related to their condition from others on the web is revealing of the seriousness of the gaps in support available from organized health care systems, as others have reported [<xref ref-type="bibr" rid="ref68">68</xref>]. As youth turn to social media for support to fill these gaps, it remains important to consider the accuracy and safety of information offered by web-based peers, accessibility to youth across a range of health literacy and technology access levels, and the potential for harm from exposure to misinformation. Steps for detecting and addressing this during clinical visits might include asking young patients about their need for information and support and their ability to access web-based resources, as well as providing links and pointers to reliable, vetted sources of web-based guidance. These &#x201C;low-tech&#x201D; strategies can be implemented among even more computationally sophisticated systems for evaluating and improving the quality and accuracy of web-based information.</p></sec><sec id="s4-2"><title>Limitations</title><p>This report draws from a convenience sample of youth, and generalizability is limited by several factors, including the focus on youth with rheumatic diseases who have access to and use the internet and social media. The study cohort consisted of youth who were previously enrolled in research, and our findings may not generalize to youth who refrain from or have limited access to research opportunities. Sociodemographic diversity is also limited. However, the clinical confirmation of disease status and availability of validated health measures (eg, PROMIS measures) are strengths. Nevertheless, the results may not generalize to youth at other clinical sites, a broader sample of youth with rheumatic diseases, youth with other chronic conditions, or youth who do not use social media. This study did not assess participants&#x2019; understanding of health information or their ability to discern information quality or misinformation. The cross-sectional nature of this study precludes causal interpretation.</p></sec><sec id="s4-3"><title>Conclusions</title><p>We found high willingness to share social media data for health research among a clinically characterized cohort of adolescents with rheumatic diseases and substantial use of social media for disease-related observational learning and social connection. Differences in health status between sharing and nonsharing youth (as well as between social media users and nonusers) underscore the importance of considering the potential for biases in research results that rely on social media data and the importance of identifying opportunities to engage and improve the health of youth who may be on the web and in need of support.</p></sec></sec></body><back><ack><p>The authors would like to acknowledge Kara Magane and Alexandra Marin for help with study planning and Sydney Pierce and Laura Blakemore for help with manuscript preparation. We thank Dr Fatma Dedeoglu, Dr Bryce B Reeve, Dr Sarah Ringold, Dr Laura E Schanberg, Dr Richard Vehe, and Dr Emily von Scheven for providing access to study registry and patient-reported outcome data. The authors wish to acknowledge the Childhood Arthritis and Rheumatology Research Alliance (CARRA) and the ongoing Arthritis Foundation financial support of CARRA. This work was funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health (NIAMS/NIH; R21AR070944-01A1).</p></ack><fn-group><fn fn-type="conflict"><p>None declared.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">AOR</term><def><p>adjusted odds ratio</p></def></def-item><def-item><term id="abb2">CARRA</term><def><p>Childhood Arthritis and Rheumatology Research Alliance</p></def></def-item><def-item><term id="abb3">JIA</term><def><p>Juvenile Idiopathic Arthritis</p></def></def-item><def-item><term id="abb4">PGA</term><def><p>Physician Global Assessment</p></def></def-item><def-item><term id="abb5">PRO</term><def><p>Patient-Reported Outcome</p></def></def-item><def-item><term id="abb6">PROMIS</term><def><p>Patient-Reported Outcomes Measurement Information System</p></def></def-item><def-item><term id="abb7">REDCap</term><def><p>Research Electronic Data Capture</p></def></def-item><def-item><term id="abb8">SLE</term><def><p>systemic lupus erythematosus</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="web"><article-title>NSCH 2018 19: number of current or lifelong health conditions, nationwide, age in 3 groups</article-title><source>National Survey of Children&#x2019;s Health Data Resource Center for Child &#x0026; Adolescent Health</source><access-date>2023-10-23</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://nschdata.org/browse/survey/results?q=7625&#x0026;g=787">nschdata.org/browse/survey/results?q=7625&#x0026;g=787</ext-link></comment></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="web"><article-title>/pub/Health_Statistics/NCHS/slaits_cshcn_survey/2009_2010/datasets/</article-title><source>Centers for Disease Control and Prevention</source><access-date>2023-11-14</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://ftp.cdc.gov/pub/Health_Statistics/NCHS/slaits_cshcn_survey/2009_2010/datasets/">ftp.cdc.gov/pub/Health_Statistics/NCHS/slaits_cshcn_survey/2009_2010/datasets/</ext-link></comment></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wisk</surname><given-names>LE</given-names></name><name name-style="western"><surname>Weitzman</surname><given-names>ER</given-names></name></person-group><article-title>Expectancy and achievement gaps in educational attainment and subsequent adverse health effects among adolescents with and without chronic medical conditions</article-title><source>J Adolesc Health</source><year>2017</year><month>10</month><volume>61</volume><issue>4</issue><fpage>461</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1016/j.jadohealth.2017.04.006</pub-id><pub-id pub-id-type="medline">28734632</pub-id></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wisk</surname><given-names>LE</given-names></name><name name-style="western"><surname>Weitzman</surname><given-names>ER</given-names></name></person-group><article-title>Social relationships and associated health effects among adolescents with and without chronic medical conditions</article-title><source>J Adolesc Health</source><year>2017</year><month>02</month><volume>60</volume><issue>2 suppl 1</issue><fpage>S19</fpage><lpage>S20</lpage><pub-id pub-id-type="doi">10.1016/j.jadohealth.2016.10.058</pub-id></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Compas</surname><given-names>BE</given-names></name><name name-style="western"><surname>Jaser</surname><given-names>SS</given-names></name><name name-style="western"><surname>Dunn</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>EM</given-names></name></person-group><article-title>Coping with chronic illness in childhood and adolescence</article-title><source>Annu Rev Clin Psychol</source><year>2012</year><volume>8</volume><fpage>455</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1146/annurev-clinpsy-032511-143108</pub-id><pub-id pub-id-type="medline">22224836</pub-id></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="web"><person-group person-group-type="author"><name name-style="western"><surname>Michaud</surname><given-names>PA</given-names></name><name name-style="western"><surname>Suris</surname><given-names>JC</given-names></name><name name-style="western"><surname>Viner</surname><given-names>R</given-names></name></person-group><article-title>The adolescent with a chronic condition: epidemiology, developmental issues and health care provision</article-title><source>World Health Organization</source><year>2007</year><month>03</month><day>28</day><access-date>2023-10-23</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://iris.who.int/bitstream/handle/10665/43775/9789241595704_eng.pdf?sequence=1">iris.who.int/bitstream/handle/10665/43775/9789241595704_eng.pdf?sequence=1</ext-link></comment></nlm-citation></ref><ref id="ref7"><label>7</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>April</surname><given-names>KT</given-names></name><name name-style="western"><surname>Cavallo</surname><given-names>S</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>DE</given-names></name></person-group><article-title>Children with juvenile idiopathic arthritis: are health outcomes better for those diagnosed younger?</article-title><source>Child Care Health Dev</source><year>2013</year><month>05</month><volume>39</volume><issue>3</issue><fpage>442</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2214.2012.01386.x</pub-id><pub-id pub-id-type="medline">22676178</pub-id></nlm-citation></ref><ref id="ref8"><label>8</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lavallee</surname><given-names>DC</given-names></name><name name-style="western"><surname>Chenok</surname><given-names>KE</given-names></name><name name-style="western"><surname>Love</surname><given-names>RM</given-names></name><etal/></person-group><article-title>Incorporating patient-reported outcomes into health care to engage patients and enhance care</article-title><source>Health Aff (Millwood)</source><year>2016</year><month>04</month><volume>35</volume><issue>4</issue><fpage>575</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1377/hlthaff.2015.1362</pub-id><pub-id pub-id-type="medline">27044954</pub-id></nlm-citation></ref><ref id="ref9"><label>9</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nap-van der Vlist</surname><given-names>MM</given-names></name><name name-style="western"><surname>Hoefnagels</surname><given-names>JW</given-names></name><name name-style="western"><surname>Dalmeijer</surname><given-names>GW</given-names></name><etal/></person-group><article-title>The PROactive cohort study: rationale, design, and study procedures</article-title><source>Eur J Epidemiol</source><year>2022</year><month>09</month><volume>37</volume><issue>9</issue><fpage>993</fpage><lpage>1002</lpage><pub-id pub-id-type="doi">10.1007/s10654-022-00889-y</pub-id><pub-id pub-id-type="medline">35980506</pub-id></nlm-citation></ref><ref id="ref10"><label>10</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forrest</surname><given-names>CB</given-names></name><name name-style="western"><surname>Schuchard</surname><given-names>J</given-names></name><name name-style="western"><surname>Bruno</surname><given-names>C</given-names></name><etal/></person-group><article-title>Self-reported health outcomes of children and youth with 10 chronic diseases</article-title><source>J Pediatr</source><year>2022</year><month>07</month><volume>246</volume><fpage>207</fpage><lpage>212.e1</lpage><pub-id pub-id-type="doi">10.1016/j.jpeds.2022.02.052</pub-id><pub-id pub-id-type="medline">35247394</pub-id></nlm-citation></ref><ref id="ref11"><label>11</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fair</surname><given-names>DC</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>M</given-names></name><name name-style="western"><surname>Knight</surname><given-names>AM</given-names></name><name name-style="western"><surname>Rubinstein</surname><given-names>TB</given-names></name></person-group><article-title>Depression and anxiety in patients with juvenile idiopathic arthritis: current insights and impact on quality of life, a systematic review</article-title><source>Open Access Rheumatol</source><year>2019</year><month>11</month><day>1</day><volume>11</volume><fpage>237</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.2147/OARRR.S174408</pub-id><pub-id pub-id-type="medline">31807093</pub-id></nlm-citation></ref><ref id="ref12"><label>12</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>JE</given-names></name><name name-style="western"><surname>Luca</surname><given-names>NJC</given-names></name><name name-style="western"><surname>Boneparth</surname><given-names>A</given-names></name><name name-style="western"><surname>Stinson</surname><given-names>J</given-names></name></person-group><article-title>Assessment and management of pain in juvenile idiopathic arthritis</article-title><source>Paediatr Drugs</source><year>2014</year><month>12</month><volume>16</volume><issue>6</issue><fpage>473</fpage><lpage>481</lpage><pub-id pub-id-type="doi">10.1007/s40272-014-0094-0</pub-id><pub-id pub-id-type="medline">25331986</pub-id></nlm-citation></ref><ref id="ref13"><label>13</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luca</surname><given-names>NJC</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>BM</given-names></name></person-group><article-title>Health outcomes of pediatric rheumatic diseases</article-title><source>Best Pract Res Clin Rheumatol</source><year>2014</year><month>04</month><volume>28</volume><issue>2</issue><fpage>331</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1016/j.berh.2014.04.001</pub-id><pub-id pub-id-type="medline">24974066</pub-id></nlm-citation></ref><ref id="ref14"><label>14</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>La Hausse de Lalouvi&#x00E8;re</surname><given-names>L</given-names></name><name name-style="western"><surname>Ioannou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fitzgerald</surname><given-names>M</given-names></name></person-group><article-title>Neural mechanisms underlying the pain of juvenile idiopathic arthritis</article-title><source>Nat Rev Rheumatol</source><year>2014</year><month>04</month><volume>10</volume><issue>4</issue><fpage>205</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1038/nrrheum.2014.4</pub-id><pub-id pub-id-type="medline">24492386</pub-id></nlm-citation></ref><ref id="ref15"><label>15</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wallace</surname><given-names>CA</given-names></name><name name-style="western"><surname>Huang</surname><given-names>B</given-names></name><name name-style="western"><surname>Bandeira</surname><given-names>M</given-names></name><name name-style="western"><surname>Ravelli</surname><given-names>A</given-names></name><name name-style="western"><surname>Giannini</surname><given-names>EH</given-names></name></person-group><article-title>Patterns of clinical remission in select categories of juvenile idiopathic arthritis</article-title><source>Arthritis Rheum</source><year>2005</year><month>11</month><volume>52</volume><issue>11</issue><fpage>3554</fpage><lpage>3562</lpage><pub-id pub-id-type="doi">10.1002/art.21389</pub-id><pub-id pub-id-type="medline">16255044</pub-id></nlm-citation></ref><ref id="ref16"><label>16</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ringold</surname><given-names>S</given-names></name><name name-style="western"><surname>Seidel</surname><given-names>KD</given-names></name><name name-style="western"><surname>Koepsell</surname><given-names>TD</given-names></name><name name-style="western"><surname>Wallace</surname><given-names>CA</given-names></name></person-group><article-title>Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations</article-title><source>Rheumatology (Oxford)</source><year>2009</year><month>08</month><volume>48</volume><issue>8</issue><fpage>972</fpage><lpage>977</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/kep144</pub-id><pub-id pub-id-type="medline">19535609</pub-id></nlm-citation></ref><ref id="ref17"><label>17</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Magni-Manzoni</surname><given-names>S</given-names></name><name name-style="western"><surname>Pistorio</surname><given-names>A</given-names></name><name name-style="western"><surname>Lab&#x00F2;</surname><given-names>E</given-names></name><etal/></person-group><article-title>A longitudinal analysis of physical functional disability over the course of juvenile idiopathic arthritis</article-title><source>Ann Rheum Dis</source><year>2008</year><month>08</month><volume>67</volume><issue>8</issue><fpage>1159</fpage><lpage>1164</lpage><pub-id pub-id-type="doi">10.1136/ard.2007.078121</pub-id><pub-id pub-id-type="medline">17965116</pub-id></nlm-citation></ref><ref id="ref18"><label>18</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamphuis</surname><given-names>S</given-names></name><name name-style="western"><surname>Silverman</surname><given-names>ED</given-names></name></person-group><article-title>Prevalence and burden of pediatric-onset systemic lupus erythematosus</article-title><source>Nat Rev Rheumatol</source><year>2010</year><month>09</month><volume>6</volume><issue>9</issue><fpage>538</fpage><lpage>546</lpage><pub-id pub-id-type="doi">10.1038/nrrheum.2010.121</pub-id><pub-id pub-id-type="medline">20683438</pub-id></nlm-citation></ref><ref id="ref19"><label>19</label><nlm-citation citation-type="web"><person-group person-group-type="author"><name name-style="western"><surname>Hersh</surname><given-names>AO</given-names></name><name name-style="western"><surname>Watkins-Castillo</surname><given-names>SI</given-names></name></person-group><article-title>Juvenile arthritis</article-title><source>The Burden of Musculoskeletal Diseases in the United States</source><access-date>2023-02-15</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.boneandjointburden.org/fourth-edition/iiib60/juvenile-arthritis">www.boneandjointburden.org/fourth-edition/iiib60/juvenile-arthritis</ext-link></comment></nlm-citation></ref><ref id="ref20"><label>20</label><nlm-citation citation-type="web"><article-title>Juvenile arthritis treatment &#x0026; diagnosis</article-title><source>National Institute of Arthritis and Musculoskeletal and Skin Diseases</source><access-date>2023-02-15</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.niams.nih.gov/health-topics/juvenile-arthritis">www.niams.nih.gov/health-topics/juvenile-arthritis</ext-link></comment></nlm-citation></ref><ref id="ref21"><label>21</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sacks</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Helmick</surname><given-names>CG</given-names></name><name name-style="western"><surname>Luo</surname><given-names>YH</given-names></name><name name-style="western"><surname>Ilowite</surname><given-names>NT</given-names></name><name name-style="western"><surname>Bowyer</surname><given-names>S</given-names></name></person-group><article-title>Prevalence of and annual ambulatory health care visits for pediatric arthritis and other rheumatologic conditions in the United States in 2001-2004</article-title><source>Arthritis Rheum</source><year>2007</year><month>12</month><day>15</day><volume>57</volume><issue>8</issue><fpage>1439</fpage><lpage>1445</lpage><pub-id pub-id-type="doi">10.1002/art.23087</pub-id><pub-id pub-id-type="medline">18050185</pub-id></nlm-citation></ref><ref id="ref22"><label>22</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seid</surname><given-names>M</given-names></name><name name-style="western"><surname>Opipari</surname><given-names>L</given-names></name><name name-style="western"><surname>Huang</surname><given-names>B</given-names></name><name name-style="western"><surname>Brunner</surname><given-names>HI</given-names></name><name name-style="western"><surname>Lovell</surname><given-names>DJ</given-names></name></person-group><article-title>Disease control and health-related quality of life in juvenile idiopathic arthritis</article-title><source>Arthritis Rheum</source><year>2009</year><month>03</month><day>15</day><volume>61</volume><issue>3</issue><fpage>393</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1002/art.24477</pub-id><pub-id pub-id-type="medline">19248113</pub-id></nlm-citation></ref><ref id="ref23"><label>23</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haverman</surname><given-names>L</given-names></name><name name-style="western"><surname>Grootenhuis</surname><given-names>MA</given-names></name><name name-style="western"><surname>van den Berg</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Predictors of health-related quality of life in children and adolescents with juvenile idiopathic arthritis: results from a web-based survey</article-title><source>Arthritis Care Res (Hoboken)</source><year>2012</year><month>05</month><volume>64</volume><issue>5</issue><fpage>694</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1002/acr.21609</pub-id><pub-id pub-id-type="medline">22238240</pub-id></nlm-citation></ref><ref id="ref24"><label>24</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guti&#x00E9;rrez-Su&#x00E1;rez</surname><given-names>R</given-names></name><name name-style="western"><surname>Pistorio</surname><given-names>A</given-names></name><name name-style="western"><surname>Cruz</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas: the PRINTO multinational quality of life cohort study</article-title><source>Rheumatology (Oxford)</source><year>2007</year><month>02</month><volume>46</volume><issue>2</issue><fpage>314</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/kel218</pub-id><pub-id pub-id-type="medline">16877459</pub-id></nlm-citation></ref><ref id="ref25"><label>25</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Minden</surname><given-names>K</given-names></name><name name-style="western"><surname>Niewerth</surname><given-names>M</given-names></name><name name-style="western"><surname>Listing</surname><given-names>J</given-names></name><etal/></person-group><article-title>Long-term outcome in patients with juvenile idiopathic arthritis</article-title><source>Arthritis Rheum</source><year>2002</year><month>09</month><volume>46</volume><issue>9</issue><fpage>2392</fpage><lpage>2401</lpage><pub-id pub-id-type="doi">10.1002/art.10444</pub-id><pub-id pub-id-type="medline">12355487</pub-id></nlm-citation></ref><ref id="ref26"><label>26</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oen</surname><given-names>K</given-names></name><name name-style="western"><surname>Malleson</surname><given-names>PN</given-names></name><name name-style="western"><surname>Cabral</surname><given-names>DA</given-names></name><name name-style="western"><surname>Rosenberg</surname><given-names>AM</given-names></name><name name-style="western"><surname>Petty</surname><given-names>RE</given-names></name><name name-style="western"><surname>Cheang</surname><given-names>M</given-names></name></person-group><article-title>Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort</article-title><source>J Rheumatol</source><year>2002</year><month>09</month><volume>29</volume><issue>9</issue><fpage>1989</fpage><lpage>1999</lpage><pub-id pub-id-type="medline">12233897</pub-id></nlm-citation></ref><ref id="ref27"><label>27</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Packham</surname><given-names>JC</given-names></name><name name-style="western"><surname>Hall</surname><given-names>MA</given-names></name><name name-style="western"><surname>Pimm</surname><given-names>TJ</given-names></name></person-group><article-title>Long-term follow-up of 246 adults with juvenile idiopathic arthritis: predictive factors for mood and pain</article-title><source>Rheumatology (Oxford)</source><year>2002</year><month>12</month><volume>41</volume><issue>12</issue><fpage>1444</fpage><lpage>1449</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/41.12.1444</pub-id><pub-id pub-id-type="medline">12468828</pub-id></nlm-citation></ref><ref id="ref28"><label>28</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zak</surname><given-names>M</given-names></name><name name-style="western"><surname>Pedersen</surname><given-names>FK</given-names></name></person-group><article-title>Juvenile chronic arthritis into adulthood: a long-term follow-up study</article-title><source>Rheumatology (Oxford)</source><year>2000</year><month>02</month><volume>39</volume><issue>2</issue><fpage>198</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/39.2.198</pub-id><pub-id pub-id-type="medline">10725073</pub-id></nlm-citation></ref><ref id="ref29"><label>29</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tucker</surname><given-names>LB</given-names></name><name name-style="western"><surname>Menon</surname><given-names>S</given-names></name><name name-style="western"><surname>Schaller</surname><given-names>JG</given-names></name><name name-style="western"><surname>Isenberg</surname><given-names>DA</given-names></name></person-group><article-title>Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome</article-title><source>Br J Rheumatol</source><year>1995</year><month>09</month><volume>34</volume><issue>9</issue><fpage>866</fpage><lpage>872</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/34.9.866</pub-id><pub-id pub-id-type="medline">7582729</pub-id></nlm-citation></ref><ref id="ref30"><label>30</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meacock</surname><given-names>R</given-names></name><name name-style="western"><surname>Dale</surname><given-names>N</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>MJ</given-names></name></person-group><article-title>The humanistic and economic burden of systemic lupus erythematosus: a systematic review</article-title><source>Pharmacoeconomics</source><year>2013</year><month>01</month><volume>31</volume><issue>1</issue><fpage>49</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1007/s40273-012-0007-4</pub-id><pub-id pub-id-type="medline">23329592</pub-id></nlm-citation></ref><ref id="ref31"><label>31</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vazzana</surname><given-names>KM</given-names></name><name name-style="western"><surname>Daga</surname><given-names>A</given-names></name><name name-style="western"><surname>Goilav</surname><given-names>B</given-names></name><etal/></person-group><article-title>Principles of pediatric lupus nephritis in a prospective contemporary multi-center cohort</article-title><source>Lupus</source><year>2021</year><month>09</month><volume>30</volume><issue>10</issue><fpage>1660</fpage><lpage>1670</lpage><pub-id pub-id-type="doi">10.1177/09612033211028658</pub-id><pub-id pub-id-type="medline">34219529</pub-id></nlm-citation></ref><ref id="ref32"><label>32</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaigne</surname><given-names>B</given-names></name><name name-style="western"><surname>Chizzolini</surname><given-names>C</given-names></name><name name-style="western"><surname>Perneger</surname><given-names>T</given-names></name><etal/></person-group><article-title>Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS)</article-title><source>BMC Immunol</source><year>2017</year><month>03</month><day>28</day><volume>18</volume><issue>1</issue><fpage>17</fpage><pub-id pub-id-type="doi">10.1186/s12865-017-0200-5</pub-id><pub-id pub-id-type="medline">28351341</pub-id></nlm-citation></ref><ref id="ref33"><label>33</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weitzman</surname><given-names>ER</given-names></name><name name-style="western"><surname>Gaultney</surname><given-names>A</given-names></name><name name-style="western"><surname>von Scheven</surname><given-names>E</given-names></name><etal/></person-group><article-title>Construct validity of patient-reported outcomes measurement information system paediatric measures in juvenile idiopathic arthritis and systemic lupus erythematosus: cross-sectional evaluation</article-title><source>BMJ Open</source><year>2023</year><month>01</month><day>27</day><volume>13</volume><issue>1</issue><fpage>e063675</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2022-063675</pub-id><pub-id pub-id-type="medline">36707118</pub-id></nlm-citation></ref><ref id="ref34"><label>34</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ancker</surname><given-names>JS</given-names></name><name name-style="western"><surname>Witteman</surname><given-names>HO</given-names></name><name name-style="western"><surname>Hafeez</surname><given-names>B</given-names></name><name name-style="western"><surname>Provencher</surname><given-names>T</given-names></name><name name-style="western"><surname>Van de Graaf</surname><given-names>M</given-names></name><name name-style="western"><surname>Wei</surname><given-names>E</given-names></name></person-group><article-title>&#x201C;You get reminded you're a sick person&#x201D;: personal data tracking and patients with multiple chronic conditions</article-title><source>J Med Internet Res</source><year>2015</year><month>08</month><day>19</day><volume>17</volume><issue>8</issue><fpage>e202</fpage><pub-id pub-id-type="doi">10.2196/jmir.4209</pub-id><pub-id pub-id-type="medline">26290186</pub-id></nlm-citation></ref><ref id="ref35"><label>35</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>CA</given-names></name><name name-style="western"><surname>Merchant</surname><given-names>RM</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>MA</given-names></name></person-group><article-title>Using social media to engage adolescents and young adults with their health</article-title><source>Healthc (Amst)</source><year>2014</year><month>12</month><volume>2</volume><issue>4</issue><fpage>220</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1016/j.hjdsi.2014.10.005</pub-id><pub-id pub-id-type="medline">25984444</pub-id></nlm-citation></ref><ref id="ref36"><label>36</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hausmann</surname><given-names>JS</given-names></name><name name-style="western"><surname>Weitzman</surname><given-names>ER</given-names></name></person-group><article-title>The promises and perils of social media for pediatric rheumatology</article-title><source>Rheum Dis Clin North Am</source><year>2022</year><month>02</month><volume>48</volume><issue>1</issue><fpage>233</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1016/j.rdc.2021.09.005</pub-id><pub-id pub-id-type="medline">34798949</pub-id></nlm-citation></ref><ref id="ref37"><label>37</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>CA</given-names></name><name name-style="western"><surname>Madanay</surname><given-names>F</given-names></name><name name-style="western"><surname>Ozer</surname><given-names>EM</given-names></name><etal/></person-group><article-title>Digital health technology to enhance adolescent and young adult clinical preventive services: affordances and challenges</article-title><source>J Adolesc Health</source><year>2020</year><month>08</month><volume>67</volume><issue>2S</issue><fpage>S24</fpage><lpage>S33</lpage><pub-id pub-id-type="doi">10.1016/j.jadohealth.2019.10.018</pub-id><pub-id pub-id-type="medline">32718511</pub-id></nlm-citation></ref><ref id="ref38"><label>38</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eggleston</surname><given-names>EM</given-names></name><name name-style="western"><surname>Weitzman</surname><given-names>ER</given-names></name></person-group><article-title>Innovative uses of electronic health records and social media for public health surveillance</article-title><source>Curr Diab Rep</source><year>2014</year><month>03</month><volume>14</volume><issue>3</issue><fpage>468</fpage><pub-id pub-id-type="doi">10.1007/s11892-013-0468-7</pub-id><pub-id pub-id-type="medline">24488369</pub-id></nlm-citation></ref><ref id="ref39"><label>39</label><nlm-citation citation-type="web"><article-title>Online privacy and safety</article-title><source>European Commission: shaping Europe's digital future</source><access-date>2023-06-14</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://digital-strategy.ec.europa.eu/en/policies/online-privacy">digital-strategy.ec.europa.eu/en/policies/online-privacy</ext-link></comment></nlm-citation></ref><ref id="ref40"><label>40</label><nlm-citation citation-type="web"><article-title>Children&#x2019;s Online Privacy Protection Rule ("COPPA")</article-title><source>Federal Trade Commission</source><access-date>2023-07-19</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.ftc.gov/legal-library/browse/rules/childrens-online-privacy-protection-rule-coppa">www.ftc.gov/legal-library/browse/rules/childrens-online-privacy-protection-rule-coppa</ext-link></comment></nlm-citation></ref><ref id="ref41"><label>41</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chunara</surname><given-names>R</given-names></name><name name-style="western"><surname>Wisk</surname><given-names>LE</given-names></name><name name-style="western"><surname>Weitzman</surname><given-names>ER</given-names></name></person-group><article-title>Denominator issues for personally generated data in population health monitoring</article-title><source>Am J Prev Med</source><year>2017</year><month>04</month><volume>52</volume><issue>4</issue><fpage>549</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1016/j.amepre.2016.10.038</pub-id><pub-id pub-id-type="medline">28012811</pub-id></nlm-citation></ref><ref id="ref42"><label>42</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Padrez</surname><given-names>KA</given-names></name><name name-style="western"><surname>Ungar</surname><given-names>L</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>HA</given-names></name><etal/></person-group><article-title>Linking social media and medical record data: a study of adults presenting to an academic, urban emergency department</article-title><source>BMJ Qual Saf</source><year>2016</year><month>06</month><volume>25</volume><issue>6</issue><fpage>414</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1136/bmjqs-2015-004489</pub-id><pub-id pub-id-type="medline">26464519</pub-id></nlm-citation></ref><ref id="ref43"><label>43</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peat</surname><given-names>G</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>A</given-names></name><name name-style="western"><surname>Smith</surname><given-names>J</given-names></name></person-group><article-title>Social media use in adolescents and young adults with serious illnesses: an integrative review</article-title><source>BMJ Support Palliat Care</source><year>2019</year><month>09</month><volume>9</volume><issue>3</issue><fpage>235</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1136/bmjspcare-2018-001646</pub-id><pub-id pub-id-type="medline">30514717</pub-id></nlm-citation></ref><ref id="ref44"><label>44</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>E</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>M</given-names></name></person-group><article-title>Health-related internet use by children and adolescents: systematic review</article-title><source>J Med Internet Res</source><year>2018</year><month>04</month><day>3</day><volume>20</volume><issue>4</issue><fpage>e120</fpage><pub-id pub-id-type="doi">10.2196/jmir.7731</pub-id><pub-id pub-id-type="medline">29615385</pub-id></nlm-citation></ref><ref id="ref45"><label>45</label><nlm-citation citation-type="web"><article-title>Childhood Arthritis and Rheumatology Research Alliance</article-title><source>CARRA</source><access-date>2023-10-23</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://carragroup.org/">carragroup.org/</ext-link></comment></nlm-citation></ref><ref id="ref46"><label>46</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fuhlbrigge</surname><given-names>RC</given-names></name><name name-style="western"><surname>Schanberg</surname><given-names>LE</given-names></name><name name-style="western"><surname>Kimura</surname><given-names>Y</given-names></name></person-group><article-title>CARRA: the Childhood Arthritis and Rheumatology Research Alliance</article-title><source>Rheum Dis Clin North Am</source><year>2021</year><month>11</month><volume>47</volume><issue>4</issue><fpage>531</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1016/j.rdc.2021.07.010</pub-id><pub-id pub-id-type="medline">34635290</pub-id></nlm-citation></ref><ref id="ref47"><label>47</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>PA</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>R</given-names></name><name name-style="western"><surname>Minor</surname><given-names>BL</given-names></name><etal/></person-group><article-title>The REDCap consortium: building an international community of software platform partners</article-title><source>J Biomed Inform</source><year>2019</year><month>07</month><volume>95</volume><fpage>103208</fpage><pub-id pub-id-type="doi">10.1016/j.jbi.2019.103208</pub-id><pub-id pub-id-type="medline">31078660</pub-id></nlm-citation></ref><ref id="ref48"><label>48</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>PA</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>R</given-names></name><name name-style="western"><surname>Thielke</surname><given-names>R</given-names></name><name name-style="western"><surname>Payne</surname><given-names>J</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>N</given-names></name><name name-style="western"><surname>Conde</surname><given-names>JG</given-names></name></person-group><article-title>Research electronic data capture (REDCap) &#x2013; a metadata-driven methodology and workflow process for providing translational research informatics support</article-title><source>J Biomed Inform</source><year>2009</year><month>04</month><volume>42</volume><issue>2</issue><fpage>377</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1016/j.jbi.2008.08.010</pub-id><pub-id pub-id-type="medline">18929686</pub-id></nlm-citation></ref><ref id="ref49"><label>49</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nikiphorou</surname><given-names>E</given-names></name><name name-style="western"><surname>Radner</surname><given-names>H</given-names></name><name name-style="western"><surname>Chatzidionysiou</surname><given-names>K</given-names></name><etal/></person-group><article-title>Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature</article-title><source>Arthritis Res Ther</source><year>2016</year><month>10</month><day>28</day><volume>18</volume><issue>1</issue><fpage>251</fpage><pub-id pub-id-type="doi">10.1186/s13075-016-1151-6</pub-id><pub-id pub-id-type="medline">27793211</pub-id></nlm-citation></ref><ref id="ref50"><label>50</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reeve</surname><given-names>BB</given-names></name><name name-style="western"><surname>Hays</surname><given-names>RD</given-names></name><name name-style="western"><surname>Bjorner</surname><given-names>JB</given-names></name><etal/></person-group><article-title>Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS)</article-title><source>Med Care</source><year>2007</year><month>05</month><volume>45</volume><issue>5 Suppl 1</issue><fpage>S22</fpage><lpage>S31</lpage><pub-id pub-id-type="doi">10.1097/01.mlr.0000250483.85507.04</pub-id><pub-id pub-id-type="medline">17443115</pub-id></nlm-citation></ref><ref id="ref51"><label>51</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Broderick</surname><given-names>JE</given-names></name><name name-style="western"><surname>DeWitt</surname><given-names>EM</given-names></name><name name-style="western"><surname>Rothrock</surname><given-names>N</given-names></name><name name-style="western"><surname>Crane</surname><given-names>PK</given-names></name><name name-style="western"><surname>Forrest</surname><given-names>CB</given-names></name></person-group><article-title>Advances in patient-reported outcomes: the NIH PROMIS(&#x00AE;) measures</article-title><source>EGEMS (Wash DC)</source><year>2013</year><month>08</month><day>2</day><volume>1</volume><issue>1</issue><fpage>1015</fpage><pub-id pub-id-type="doi">10.13063/2327-9214.1015</pub-id><pub-id pub-id-type="medline">25848562</pub-id></nlm-citation></ref><ref id="ref52"><label>52</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carle</surname><given-names>AC</given-names></name><name name-style="western"><surname>Bevans</surname><given-names>KB</given-names></name><name name-style="western"><surname>Tucker</surname><given-names>CA</given-names></name><name name-style="western"><surname>Forrest</surname><given-names>CB</given-names></name></person-group><article-title>Using nationally representative percentiles to interpret PROMIS pediatric measures</article-title><source>Qual Life Res</source><year>2021</year><month>04</month><volume>30</volume><issue>4</issue><fpage>997</fpage><lpage>1004</lpage><pub-id pub-id-type="doi">10.1007/s11136-020-02700-5</pub-id><pub-id pub-id-type="medline">33201388</pub-id></nlm-citation></ref><ref id="ref53"><label>53</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thissen</surname><given-names>D</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Magnus</surname><given-names>B</given-names></name><etal/></person-group><article-title>Estimating minimally important difference (MID) in PROMIS pediatric measures using the scale-judgment method</article-title><source>Qual Life Res</source><year>2016</year><month>01</month><volume>25</volume><issue>1</issue><fpage>13</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1007/s11136-015-1058-8</pub-id><pub-id pub-id-type="medline">26118768</pub-id></nlm-citation></ref><ref id="ref54"><label>54</label><nlm-citation citation-type="web"><article-title>SAS: analytics, artificial intelligence and data management</article-title><source>SAS Institute</source><access-date>2023-07-23</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.sas.com/en_us/home.html">www.sas.com/en_us/home.html</ext-link></comment></nlm-citation></ref><ref id="ref55"><label>55</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chau</surname><given-names>MM</given-names></name><name name-style="western"><surname>Burgermaster</surname><given-names>M</given-names></name><name name-style="western"><surname>Mamykina</surname><given-names>L</given-names></name></person-group><article-title>The use of social media in nutrition interventions for adolescents and young adults-a systematic review</article-title><source>Int J Med Inform</source><year>2018</year><month>12</month><volume>120</volume><fpage>77</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.ijmedinf.2018.10.001</pub-id><pub-id pub-id-type="medline">30409348</pub-id></nlm-citation></ref><ref id="ref56"><label>56</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wicks</surname><given-names>P</given-names></name><name name-style="western"><surname>Thorley</surname><given-names>EM</given-names></name><name name-style="western"><surname>Simacek</surname><given-names>K</given-names></name><name name-style="western"><surname>Curran</surname><given-names>C</given-names></name><name name-style="western"><surname>Emmas</surname><given-names>C</given-names></name></person-group><article-title>Scaling PatientsLikeMe via a &#x201C;generalized platform&#x201D; for members with chronic illness: web-based survey study of benefits arising</article-title><source>J Med Internet Res</source><year>2018</year><month>05</month><day>7</day><volume>20</volume><issue>5</issue><fpage>e175</fpage><pub-id pub-id-type="doi">10.2196/jmir.9909</pub-id><pub-id pub-id-type="medline">29735472</pub-id></nlm-citation></ref><ref id="ref57"><label>57</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rothman</surname><given-names>M</given-names></name><name name-style="western"><surname>Gnanaskathy</surname><given-names>A</given-names></name><name name-style="western"><surname>Wicks</surname><given-names>P</given-names></name><name name-style="western"><surname>Papadopoulos</surname><given-names>EJ</given-names></name></person-group><article-title>Can we use social media to support content validity of patient-reported outcome instruments in medical product development?</article-title><source>Value Health</source><year>2015</year><month>01</month><volume>18</volume><issue>1</issue><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/j.jval.2014.10.001</pub-id><pub-id pub-id-type="medline">25595228</pub-id></nlm-citation></ref><ref id="ref58"><label>58</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weitzman</surname><given-names>ER</given-names></name><name name-style="western"><surname>Adida</surname><given-names>B</given-names></name><name name-style="western"><surname>Kelemen</surname><given-names>S</given-names></name><name name-style="western"><surname>Mandl</surname><given-names>KD</given-names></name></person-group><article-title>Sharing data for public health research by members of an international online diabetes social network</article-title><source>PLoS One</source><year>2011</year><month>04</month><day>27</day><volume>6</volume><issue>4</issue><fpage>e19256</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0019256</pub-id><pub-id pub-id-type="medline">21556358</pub-id></nlm-citation></ref><ref id="ref59"><label>59</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weitzman</surname><given-names>ER</given-names></name><name name-style="western"><surname>Kelemen</surname><given-names>S</given-names></name><name name-style="western"><surname>Kaci</surname><given-names>L</given-names></name><name name-style="western"><surname>Mandl</surname><given-names>KD</given-names></name></person-group><article-title>Willingness to share personal health record data for care improvement and public health: a survey of experienced personal health record users</article-title><source>BMC Med Inform Decis Mak</source><year>2012</year><month>05</month><day>22</day><volume>12</volume><fpage>39</fpage><pub-id pub-id-type="doi">10.1186/1472-6947-12-39</pub-id><pub-id pub-id-type="medline">22616619</pub-id></nlm-citation></ref><ref id="ref60"><label>60</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>P</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L</given-names></name><name name-style="western"><surname>Tang</surname><given-names>T</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name><name name-style="western"><surname>Huang</surname><given-names>C</given-names></name></person-group><article-title>Users&#x2019; willingness to share health information in a social question-and-answer community: cross-sectional survey in China</article-title><source>JMIR Med Inform</source><year>2021</year><month>03</month><day>30</day><volume>9</volume><issue>3</issue><fpage>e26265</fpage><pub-id pub-id-type="doi">10.2196/26265</pub-id><pub-id pub-id-type="medline">33783364</pub-id></nlm-citation></ref><ref id="ref61"><label>61</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grande</surname><given-names>D</given-names></name><name name-style="western"><surname>Mitra</surname><given-names>N</given-names></name><name name-style="western"><surname>Iyengar</surname><given-names>R</given-names></name><etal/></person-group><article-title>Consumer willingness to share personal digital information for health-related uses</article-title><source>JAMA Netw Open</source><year>2022</year><month>01</month><day>4</day><volume>5</volume><issue>1</issue><fpage>e2144787</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.44787</pub-id><pub-id pub-id-type="medline">35072717</pub-id></nlm-citation></ref><ref id="ref62"><label>62</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weitzman</surname><given-names>ER</given-names></name><name name-style="western"><surname>Cole</surname><given-names>E</given-names></name><name name-style="western"><surname>Kaci</surname><given-names>L</given-names></name><name name-style="western"><surname>Mandl</surname><given-names>KD</given-names></name></person-group><article-title>Social but safe? quality and safety of diabetes-related online social networks</article-title><source>J Am Med Inform Assoc</source><year>2011</year><month>05</month><day>1</day><volume>18</volume><issue>3</issue><fpage>292</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1136/jamia.2010.009712</pub-id><pub-id pub-id-type="medline">21262920</pub-id></nlm-citation></ref><ref id="ref63"><label>63</label><nlm-citation citation-type="web"><person-group person-group-type="author"><name name-style="western"><surname>Lenhart</surname><given-names>A</given-names></name></person-group><article-title>Teens, social media &#x0026; technology overview 2015</article-title><source>Pew Research Center</source><year>2015</year><month>04</month><day>9</day><access-date>2023-07-23</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.pewresearch.org/internet/2015/04/09/teens-social-media-technology-2015/">www.pewresearch.org/internet/2015/04/09/teens-social-media-technology-2015/</ext-link></comment></nlm-citation></ref><ref id="ref64"><label>64</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weitzman</surname><given-names>ER</given-names></name><name name-style="western"><surname>Kaci</surname><given-names>L</given-names></name><name name-style="western"><surname>Quinn</surname><given-names>M</given-names></name><name name-style="western"><surname>Mandl</surname><given-names>KD</given-names></name></person-group><article-title>Helping high-risk youth move through high-risk periods: personally controlled health records for improving social and health care transitions</article-title><source>J Diabetes Sci Technol</source><year>2011</year><month>01</month><day>1</day><volume>5</volume><issue>1</issue><fpage>47</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1177/193229681100500107</pub-id><pub-id pub-id-type="medline">21303624</pub-id></nlm-citation></ref><ref id="ref65"><label>65</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weitzman</surname><given-names>ER</given-names></name><name name-style="western"><surname>Magane</surname><given-names>KM</given-names></name><name name-style="western"><surname>Wisk</surname><given-names>LE</given-names></name></person-group><article-title>How returning aggregate research results impacts interest in research engagement and planned actions relevant to health care decision making: cohort study</article-title><source>J Med Internet Res</source><year>2018</year><month>12</month><day>21</day><volume>20</volume><issue>12</issue><fpage>e10647</fpage><pub-id pub-id-type="doi">10.2196/10647</pub-id><pub-id pub-id-type="medline">30578228</pub-id></nlm-citation></ref><ref id="ref66"><label>66</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldberg</surname><given-names>EM</given-names></name><name name-style="western"><surname>Rosen</surname><given-names>RK</given-names></name><name name-style="western"><surname>Dizon</surname><given-names>DS</given-names></name><etal/></person-group><article-title>Using social media for clinical research: recommendations and examples from the Brown-Lifespan Center for Digital Health</article-title><source>J Med Internet Res</source><year>2022</year><month>06</month><day>13</day><volume>24</volume><issue>6</issue><fpage>e35804</fpage><pub-id pub-id-type="doi">10.2196/35804</pub-id><pub-id pub-id-type="medline">35700012</pub-id></nlm-citation></ref><ref id="ref67"><label>67</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Houtrow</surname><given-names>A</given-names></name><name name-style="western"><surname>Harris</surname><given-names>D</given-names></name><name name-style="western"><surname>Molinero</surname><given-names>A</given-names></name><name name-style="western"><surname>Levin-Decanini</surname><given-names>T</given-names></name><name name-style="western"><surname>Robichaud</surname><given-names>C</given-names></name></person-group><article-title>Children with disabilities in the United States and the COVID-19 pandemic</article-title><source>J Pediatr Rehabil Med</source><year>2020</year><volume>13</volume><issue>3</issue><fpage>415</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.3233/PRM-200769</pub-id><pub-id pub-id-type="medline">33185616</pub-id></nlm-citation></ref><ref id="ref68"><label>68</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knight</surname><given-names>A</given-names></name><name name-style="western"><surname>Vickery</surname><given-names>M</given-names></name><name name-style="western"><surname>Faust</surname><given-names>L</given-names></name><etal/></person-group><article-title>Gaps in mental health care for youth with rheumatologic conditions: a mixed methods study of perspectives from behavioral health providers</article-title><source>Arthritis Care Res (Hoboken)</source><year>2019</year><month>05</month><volume>71</volume><issue>5</issue><fpage>591</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1002/acr.23683</pub-id><pub-id pub-id-type="medline">29953741</pub-id></nlm-citation></ref></ref-list></back></article>